p17 艾滋病毒媒介淋巴发育的变异表达和演变
Nicoleta Arnaut1, Mark Slevin1, Claudia Bănescu1,2
1Centre for Advanced Medical and Pharmaceutical Research, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology, 540142 Targu Mures, Romania.
Viruses
|April 26, 2025
概括
具有C端氨基酸插入的特定p17变体 (vp17s) 在HIV-1和淋巴瘤患者中更常见. 这些vp17s可能作为HIV阳性患者淋巴瘤风险的生物标志物.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 非霍奇金淋巴瘤 (NHL) 是人类免疫缺陷病毒 (HIV-1) 患者的主要死亡原因,尽管结合抗逆转录病毒治疗 (cART) 仍然存在.
- 驱动HIV-1阳性个体B细胞瘤发生的精确机制尚未完全理解.
- 最近的研究强调了p17变体 (vp17s) 在淋巴瘤发展中的重要作用.
研究的目的:
- 阐明特定的p17变体 (vp17s) 在HIV-1阳性个体中淋巴发育中的作用.
- 评估vp17s作为诊断和预后标志物的潜力,以识别高风险淋巴瘤患者.
- 探索vp17s对淋巴瘤发展有所贡献的分子机制.
主要方法:
- 在HIV-1阳性,有和没有淋巴瘤的个体中对VP17序列的比较分析.
- 利用超深度测序技术,如下一代测序,进行全面的vp17分析.
- 研究改变的vp17s与蛋白酶激活受体-1 (PAR-1) 和下游信号通路,如蛋白激酶B的相互作用.
主要成果:
- 具有特定C端氨基酸插入的vp17s (在位置114-115,117-118,和125-126) 在HIV-1阳性淋巴瘤患者中明显更为普遍,与没有的患者相比.
- 这些变化破坏了vp17蛋白的稳定,暴露了与PAR-1相互作用的功能性表位.
- 这种相互作用刺激蛋白激酶B通路,这表明这些vp17变体的致癌作用.
结论:
- 具有C端氨基酸插入的特定vp17变体与HIV-1阳性个体的淋巴瘤发展密切相关.
- 这些淋巴发育性vp17s代表了在这个人群中早期检测和淋巴瘤风险分层的潜在生物标志物.
- 下一代测序可以成为查和监测HIV-1阳性患者的宝贵工具,从而实现针对淋巴瘤的有针对性的预防策略.
相关概念视频
Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K
Viral Mutations
32.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.0K
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
Epistasis
43.5K
In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
43.5K
LTR Retrotransposons
17.2K
LTR retrotransposons are class I transposable elements with long terminal repeats flanking an internal coding region. These elements are less abundant in mammals compared to other class I transposable elements. About 8 percent of human genomic DNA comprises LTR retrotransposons. Some of the common examples of LTR retrotransposons are Ty elements in yeast and Copia elements in Drosophila.
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
17.2K


